| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.085 | 0.02 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | 0.095 | 0.02 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | MK 1775 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.02 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.096 | 0.02 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.02 |